glp-1 announcement today Novo Nordisk, Lilly strike deal with Trump to slash weight-loss drug prices GLP-1 Pipeline Update: August 2025

Long COVID or post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms

Spaight C, Gross J, Horsch A, Puder JJ

Final Thoughts IGF-1 LR3 offers undeniable scientific intrigue its ability to extend growth signals and enhance muscle repair is impressive

History of Type 2 Diabetes or Obesity You may also be eligible for GLP-1 treatment if you have a medical history of type 2 diabetes, heart disease, or both

Mindfulness-based interventions have shown promise in reducing food cravings and improving eating awareness, helping individuals distinguish between physiological hunger and psychological food preoccupation